Lilly Moves Ahead With Retevmo Launch In A Challenging Environment

 
• By Jessica Merrill
  
FDA approved background, 3D rendering, blue street sign
Lilly will launch the RET inhibitor despite coronavirus-related limitations
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip